Redeye updates its estimates after AddLife's Q3 2026 report. Net sales and adjusted EBITA were in line with our expectations and consensus, while the headline EPS beat stems from a SEK32m non-cash remeasurement of contingent considerations. Acquisitions drove the improvement in profit, and organic operating leverage is still to come. We have moved to a more granular model and raise our fair value from SEK185 to SEK189.
LÄS MER
